UNICON OPTICAL CO., LTD. Unicon Optical Co., Ltd. Stock
Equities
4150
TW0004150008
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.75 TWD | -4.29% |
|
-20.99% | +64.22% |
| 2023 | International Business Unit to Sell Contact Lens Business | MT |
| 2023 | IB Settlement Unit in Negotiations to Receive 100 Million Yuan Capital Injection from Eyebright Medical | MT |
| Sales 2021 | 898M 27.6M | Sales 2022 | 825M 25.36M | Capitalization | 1.28B 39.22M |
|---|---|---|---|---|---|
| Net income 2021 | -293M -9M | Net income 2022 | -254M -7.8M | EV / Sales 2021 | 1.76 x |
| Net Debt 2021 | 25.66M 789K | Net Debt 2022 | 34.22M 1.05M | EV / Sales 2022 | 1.59 x |
| P/E ratio 2021 |
-5.17
x | P/E ratio 2022 |
-5.03
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 53.11% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.29% | ||
| 1 week | -20.99% | ||
| Current month | -29.03% | ||
| 1 month | -26.86% | ||
| 3 months | +16.32% | ||
| 6 months | +61.06% | ||
| Current year | +64.22% |
1 week
16.00
20.70
1 month
16.0026.25
Current year
10.0527.00
1 year
9.9027.00
3 years
7.4727.00
5 years
7.4784.45
10 years
7.4784.45
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Cheng Lin
CEO | Chief Executive Officer | - | 20-11-01 |
Mei I Yu
DFI | Director of Finance/CFO | - | - |
Pei De Jeng
CTO | Chief Tech/Sci/R&D Officer | - | 17-06-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shan Hsia Lin
BRD | Director/Board Member | - | 19-06-19 |
Wan Chun Yan
IRC | Investor Relations Contact | - | - |
| Chairman | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 16.75 | -4.29% | 3 864 382 |
| 24-04-22 | 17.5 | -8.85% | 2,501,962 |
| 24-04-19 | 19.2 | -2.29% | 1,509,278 |
| 24-04-18 | 19.65 | -2.96% | 1,334,892 |
| 24-04-17 | 20.25 | +3.58% | 1,272,546 |
End-of-day quote Taipei Exchange, April 22, 2024
More quotes
UNICON OPTICAL CO., LTD. is a Taiwan-based company principally engaged in the production and sales of contact lenses. The Companyâs main business is mainly engaged in the research, design, development, manufacture and sales of daily disposable, monthly disposable soft contact lenses, daily disposable, monthly disposable make-up contact lenses, hydrophobic contact lenses and drug release contact lenses. The Companyâs products can be divided into myopia and farsighted lenses for vision correctness and corneal photochromic lenses that change the color of the iris. The Company distributes its products both in domestic markets and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| +64.22% | 78.92M | |
| +12.78% | 97.69B | |
| +12.40% | 39.6B | |
| -3.21% | 17.9B | |
| -23.03% | 2.12B | |
| -5.25% | 1.46B | |
| +21.69% | 1.09B | |
| -38.53% | 759M | |
| -36.57% | 740M | |
| -12.09% | 613M |
- Stock Market
- Equities
- 4150 Stock
